News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enzymotec Announces It Has Been Granted Patents For INFAT®'S Uses In Canada And The US


2/3/2014 9:03:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIGDAL HA'EMEQ, Israel, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that it was granted a patent by the Canadian Patent and Trademark Office for the use of INFATĀ® for the promotion of intestinal development and maturation, and further announced that it was granted a patent by the U.S. Patent and Trademark Office for the use of INFATĀ® in enhancing infant bone strength.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
Enzymotec
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES